nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—CYP2D6—Temsirolimus—kidney cancer	0.123	0.156	CbGbCtD
Pyrimethamine—CYP2C8—Pazopanib—kidney cancer	0.101	0.128	CbGbCtD
Pyrimethamine—CYP2C9—Capecitabine—kidney cancer	0.0738	0.0932	CbGbCtD
Pyrimethamine—CYP2C8—Erlotinib—kidney cancer	0.0723	0.0915	CbGbCtD
Pyrimethamine—CYP2C8—Paclitaxel—kidney cancer	0.0662	0.0837	CbGbCtD
Pyrimethamine—CYP2D6—Pazopanib—kidney cancer	0.0647	0.0817	CbGbCtD
Pyrimethamine—CYP2C8—Sorafenib—kidney cancer	0.0588	0.0744	CbGbCtD
Pyrimethamine—CYP2C9—Paclitaxel—kidney cancer	0.0462	0.0584	CbGbCtD
Pyrimethamine—CYP2D6—Erlotinib—kidney cancer	0.0461	0.0583	CbGbCtD
Pyrimethamine—CYP2C9—Sorafenib—kidney cancer	0.041	0.0519	CbGbCtD
Pyrimethamine—CYP2D6—Sorafenib—kidney cancer	0.0375	0.0474	CbGbCtD
Pyrimethamine—CYP2D6—Vinblastine—kidney cancer	0.037	0.0468	CbGbCtD
Pyrimethamine—CYP2D6—Doxorubicin—kidney cancer	0.0228	0.0288	CbGbCtD
Pyrimethamine—CYP2C9—urine—kidney cancer	0.00456	0.17	CbGeAlD
Pyrimethamine—CYP2D6—urine—kidney cancer	0.00342	0.128	CbGeAlD
Pyrimethamine—DHFR—nephron tubule—kidney cancer	0.00278	0.104	CbGeAlD
Pyrimethamine—Stevens-Johnson syndrome—Temsirolimus—kidney cancer	0.0027	0.0196	CcSEcCtD
Pyrimethamine—Haematuria—Temsirolimus—kidney cancer	0.00259	0.0189	CcSEcCtD
Pyrimethamine—DHFR—renal system—kidney cancer	0.00253	0.0945	CbGeAlD
Pyrimethamine—DHFR—kidney—kidney cancer	0.00245	0.0914	CbGeAlD
Pyrimethamine—Haematuria—Pazopanib—kidney cancer	0.00244	0.0178	CcSEcCtD
Pyrimethamine—DHFR—cortex of kidney—kidney cancer	0.00238	0.089	CbGeAlD
Pyrimethamine—Erythema multiforme—Temsirolimus—kidney cancer	0.00231	0.0168	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Erlotinib—kidney cancer	0.00228	0.0166	CcSEcCtD
Pyrimethamine—DHFR—gonad—kidney cancer	0.00227	0.0847	CbGeAlD
Pyrimethamine—DHFR—cardiac atrium—kidney cancer	0.00227	0.0846	CbGeAlD
Pyrimethamine—Pancytopenia—Vinblastine—kidney cancer	0.00216	0.0157	CcSEcCtD
Pyrimethamine—Pancytopenia—Everolimus—kidney cancer	0.00216	0.0157	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Sorafenib—kidney cancer	0.00205	0.0149	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Sunitinib—kidney cancer	0.00197	0.0144	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Erlotinib—kidney cancer	0.00194	0.0141	CcSEcCtD
Pyrimethamine—Haematuria—Everolimus—kidney cancer	0.00193	0.014	CcSEcCtD
Pyrimethamine—Leukopenia—Temsirolimus—kidney cancer	0.0019	0.0138	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Dactinomycin—kidney cancer	0.00187	0.0136	CcSEcCtD
Pyrimethamine—Pancytopenia—Sunitinib—kidney cancer	0.0018	0.0131	CcSEcCtD
Pyrimethamine—Leukopenia—Pazopanib—kidney cancer	0.00179	0.013	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Sorafenib—kidney cancer	0.00174	0.0127	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Temsirolimus—kidney cancer	0.00173	0.0126	CcSEcCtD
Pyrimethamine—Pancytopenia—Dactinomycin—kidney cancer	0.0017	0.0124	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Temsirolimus—kidney cancer	0.0017	0.0124	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Sunitinib—kidney cancer	0.00168	0.0122	CcSEcCtD
Pyrimethamine—Erythema multiforme—Erlotinib—kidney cancer	0.00166	0.0121	CcSEcCtD
Pyrimethamine—Anorexia—Temsirolimus—kidney cancer	0.00165	0.012	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Pazopanib—kidney cancer	0.0016	0.0116	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Dactinomycin—kidney cancer	0.00159	0.0115	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Gemcitabine—kidney cancer	0.00158	0.0115	CcSEcCtD
Pyrimethamine—Anorexia—Pazopanib—kidney cancer	0.00156	0.0113	CcSEcCtD
Pyrimethamine—Pancytopenia—Vincristine—kidney cancer	0.00152	0.0111	CcSEcCtD
Pyrimethamine—Decreased appetite—Temsirolimus—kidney cancer	0.00151	0.011	CcSEcCtD
Pyrimethamine—Erythema multiforme—Sorafenib—kidney cancer	0.00149	0.0108	CcSEcCtD
Pyrimethamine—Pancytopenia—Gemcitabine—kidney cancer	0.00144	0.0105	CcSEcCtD
Pyrimethamine—Erythema multiforme—Sunitinib—kidney cancer	0.00143	0.0104	CcSEcCtD
Pyrimethamine—Leukopenia—Vinblastine—kidney cancer	0.00142	0.0103	CcSEcCtD
Pyrimethamine—Decreased appetite—Pazopanib—kidney cancer	0.00142	0.0103	CcSEcCtD
Pyrimethamine—Leukopenia—Everolimus—kidney cancer	0.00142	0.0103	CcSEcCtD
Pyrimethamine—Erythema multiforme—Dactinomycin—kidney cancer	0.00136	0.00988	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.00134	0.00978	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.00133	0.00965	CcSEcCtD
Pyrimethamine—Lamotrigine—ABCB1—kidney cancer	0.00133	1	CrCbGaD
Pyrimethamine—Haematuria—Gemcitabine—kidney cancer	0.00129	0.00941	CcSEcCtD
Pyrimethamine—Hypersensitivity—Temsirolimus—kidney cancer	0.00128	0.0093	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Vinblastine—kidney cancer	0.00127	0.00923	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Everolimus—kidney cancer	0.00126	0.00919	CcSEcCtD
Pyrimethamine—CYP2C8—renal system—kidney cancer	0.00126	0.0469	CbGeAlD
Pyrimethamine—Anorexia—Vinblastine—kidney cancer	0.00123	0.00898	CcSEcCtD
Pyrimethamine—Anorexia—Everolimus—kidney cancer	0.00123	0.00895	CcSEcCtD
Pyrimethamine—Leukopenia—Sorafenib—kidney cancer	0.00123	0.00894	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Erlotinib—kidney cancer	0.00122	0.00887	CcSEcCtD
Pyrimethamine—CYP2C8—kidney—kidney cancer	0.00121	0.0454	CbGeAlD
Pyrimethamine—Pancytopenia—Paclitaxel—kidney cancer	0.00121	0.0088	CcSEcCtD
Pyrimethamine—Anorexia—Erlotinib—kidney cancer	0.00119	0.00863	CcSEcCtD
Pyrimethamine—Leukopenia—Sunitinib—kidney cancer	0.00118	0.0086	CcSEcCtD
Pyrimethamine—Erythema multiforme—Gemcitabine—kidney cancer	0.00115	0.00837	CcSEcCtD
Pyrimethamine—Decreased appetite—Vinblastine—kidney cancer	0.00113	0.00819	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.00113	0.00819	CcSEcCtD
Pyrimethamine—Decreased appetite—Everolimus—kidney cancer	0.00112	0.00816	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Sorafenib—kidney cancer	0.00112	0.00815	CcSEcCtD
Pyrimethamine—Leukopenia—Dactinomycin—kidney cancer	0.00112	0.00814	CcSEcCtD
Pyrimethamine—Vomiting—Temsirolimus—kidney cancer	0.0011	0.00802	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Sorafenib—kidney cancer	0.0011	0.00798	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.00109	0.00792	CcSEcCtD
Pyrimethamine—Haematuria—Paclitaxel—kidney cancer	0.00108	0.00787	CcSEcCtD
Pyrimethamine—Decreased appetite—Erlotinib—kidney cancer	0.00108	0.00787	CcSEcCtD
Pyrimethamine—Anorexia—Sorafenib—kidney cancer	0.00107	0.00777	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Sunitinib—kidney cancer	0.00106	0.00768	CcSEcCtD
Pyrimethamine—Vomiting—Pazopanib—kidney cancer	0.00104	0.00756	CcSEcCtD
Pyrimethamine—Anorexia—Sunitinib—kidney cancer	0.00103	0.00747	CcSEcCtD
Pyrimethamine—Leukopenia—Vincristine—kidney cancer	0.001	0.00727	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Dactinomycin—kidney cancer	0.000999	0.00727	CcSEcCtD
Pyrimethamine—Pancytopenia—Capecitabine—kidney cancer	0.000992	0.00722	CcSEcCtD
Pyrimethamine—Decreased appetite—Sorafenib—kidney cancer	0.000974	0.00708	CcSEcCtD
Pyrimethamine—Anorexia—Dactinomycin—kidney cancer	0.000973	0.00708	CcSEcCtD
Pyrimethamine—Erythema multiforme—Paclitaxel—kidney cancer	0.000964	0.00701	CcSEcCtD
Pyrimethamine—Hypersensitivity—Vinblastine—kidney cancer	0.000954	0.00694	CcSEcCtD
Pyrimethamine—Hypersensitivity—Everolimus—kidney cancer	0.000951	0.00692	CcSEcCtD
Pyrimethamine—Leukopenia—Gemcitabine—kidney cancer	0.000949	0.0069	CcSEcCtD
Pyrimethamine—Decreased appetite—Sunitinib—kidney cancer	0.000937	0.00682	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000924	0.00672	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Vincristine—kidney cancer	0.000912	0.00663	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Vincristine—kidney cancer	0.000893	0.00649	CcSEcCtD
Pyrimethamine—Haematuria—Capecitabine—kidney cancer	0.000888	0.00646	CcSEcCtD
Pyrimethamine—Decreased appetite—Dactinomycin—kidney cancer	0.000887	0.00645	CcSEcCtD
Pyrimethamine—Anorexia—Vincristine—kidney cancer	0.000869	0.00632	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000865	0.00629	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Gemcitabine—kidney cancer	0.000847	0.00616	CcSEcCtD
Pyrimethamine—CYP2D6—renal system—kidney cancer	0.000837	0.0313	CbGeAlD
Pyrimethamine—Hypersensitivity—Sorafenib—kidney cancer	0.000825	0.006	CcSEcCtD
Pyrimethamine—Anorexia—Gemcitabine—kidney cancer	0.000824	0.006	CcSEcCtD
Pyrimethamine—Vomiting—Vinblastine—kidney cancer	0.000824	0.00599	CcSEcCtD
Pyrimethamine—Vomiting—Everolimus—kidney cancer	0.00082	0.00597	CcSEcCtD
Pyrimethamine—CYP2D6—kidney—kidney cancer	0.00081	0.0302	CbGeAlD
Pyrimethamine—Leukopenia—Paclitaxel—kidney cancer	0.000794	0.00578	CcSEcCtD
Pyrimethamine—Hypersensitivity—Sunitinib—kidney cancer	0.000794	0.00578	CcSEcCtD
Pyrimethamine—Decreased appetite—Vincristine—kidney cancer	0.000793	0.00577	CcSEcCtD
Pyrimethamine—Vomiting—Erlotinib—kidney cancer	0.000792	0.00576	CcSEcCtD
Pyrimethamine—Erythema multiforme—Capecitabine—kidney cancer	0.000791	0.00575	CcSEcCtD
Pyrimethamine—Decreased appetite—Gemcitabine—kidney cancer	0.000752	0.00547	CcSEcCtD
Pyrimethamine—Hypersensitivity—Dactinomycin—kidney cancer	0.000752	0.00547	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000724	0.00527	CcSEcCtD
Pyrimethamine—Vomiting—Sorafenib—kidney cancer	0.000712	0.00518	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000709	0.00516	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000702	0.00511	CcSEcCtD
Pyrimethamine—Anorexia—Paclitaxel—kidney cancer	0.00069	0.00502	CcSEcCtD
Pyrimethamine—Vomiting—Sunitinib—kidney cancer	0.000685	0.00499	CcSEcCtD
Pyrimethamine—Hypersensitivity—Vincristine—kidney cancer	0.000672	0.00489	CcSEcCtD
Pyrimethamine—Leukopenia—Capecitabine—kidney cancer	0.000652	0.00474	CcSEcCtD
Pyrimethamine—Vomiting—Dactinomycin—kidney cancer	0.000649	0.00472	CcSEcCtD
Pyrimethamine—Pancytopenia—Doxorubicin—kidney cancer	0.00064	0.00465	CcSEcCtD
Pyrimethamine—Decreased appetite—Paclitaxel—kidney cancer	0.000629	0.00458	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000595	0.00433	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Capecitabine—kidney cancer	0.000582	0.00423	CcSEcCtD
Pyrimethamine—Vomiting—Vincristine—kidney cancer	0.00058	0.00422	CcSEcCtD
Pyrimethamine—Haematuria—Doxorubicin—kidney cancer	0.000573	0.00417	CcSEcCtD
Pyrimethamine—Anorexia—Capecitabine—kidney cancer	0.000566	0.00412	CcSEcCtD
Pyrimethamine—Vomiting—Gemcitabine—kidney cancer	0.00055	0.004	CcSEcCtD
Pyrimethamine—Hypersensitivity—Paclitaxel—kidney cancer	0.000533	0.00388	CcSEcCtD
Pyrimethamine—Decreased appetite—Capecitabine—kidney cancer	0.000517	0.00376	CcSEcCtD
Pyrimethamine—Erythema multiforme—Doxorubicin—kidney cancer	0.00051	0.00371	CcSEcCtD
Pyrimethamine—Vomiting—Paclitaxel—kidney cancer	0.00046	0.00335	CcSEcCtD
Pyrimethamine—Hypersensitivity—Capecitabine—kidney cancer	0.000438	0.00318	CcSEcCtD
Pyrimethamine—Leukopenia—Doxorubicin—kidney cancer	0.00042	0.00306	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000383	0.00279	CcSEcCtD
Pyrimethamine—Vomiting—Capecitabine—kidney cancer	0.000378	0.00275	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Doxorubicin—kidney cancer	0.000375	0.00273	CcSEcCtD
Pyrimethamine—Anorexia—Doxorubicin—kidney cancer	0.000365	0.00266	CcSEcCtD
Pyrimethamine—Decreased appetite—Doxorubicin—kidney cancer	0.000333	0.00242	CcSEcCtD
Pyrimethamine—Hypersensitivity—Doxorubicin—kidney cancer	0.000282	0.00205	CcSEcCtD
Pyrimethamine—Vomiting—Doxorubicin—kidney cancer	0.000244	0.00177	CcSEcCtD
Pyrimethamine—DHFR—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	0.000138	0.00319	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GLIPR1—kidney cancer	0.000138	0.00318	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PPAT—kidney cancer	0.000138	0.00318	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—PSMD7—kidney cancer	0.000137	0.00316	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—AURKA—kidney cancer	0.000134	0.00308	CbGpPWpGaD
Pyrimethamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000134	0.00308	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—ST3GAL2—kidney cancer	0.000133	0.00307	CbGpPWpGaD
Pyrimethamine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000132	0.00305	CbGpPWpGaD
Pyrimethamine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000132	0.00304	CbGpPWpGaD
Pyrimethamine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000132	0.00304	CbGpPWpGaD
Pyrimethamine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000131	0.00301	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—APRT—kidney cancer	0.000128	0.00296	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—FH—kidney cancer	0.000128	0.00296	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SLC5A3—kidney cancer	0.000125	0.00288	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PGK1—kidney cancer	0.000125	0.00288	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—LDHB—kidney cancer	0.000123	0.00282	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SFRP2—kidney cancer	0.000123	0.00282	CbGpPWpGaD
Pyrimethamine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000121	0.00279	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GPC3—kidney cancer	0.000121	0.00278	CbGpPWpGaD
Pyrimethamine—DHFR—Mitotic G1-G1/S phases—MYC—kidney cancer	0.000119	0.00273	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CA2—kidney cancer	0.000118	0.00271	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—GSTT1—kidney cancer	0.000116	0.00267	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ALAD—kidney cancer	0.000115	0.00264	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TCEB1—kidney cancer	0.000114	0.00263	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TCEB2—kidney cancer	0.000114	0.00263	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—CDKN2B—kidney cancer	0.000112	0.00258	CbGpPWpGaD
Pyrimethamine—CYP2C8—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000112	0.00258	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ST3GAL2—kidney cancer	0.000112	0.00257	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ALDH1A1—kidney cancer	0.000109	0.00252	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—PTGS1—kidney cancer	0.000109	0.0025	CbGpPWpGaD
Pyrimethamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000108	0.00249	CbGpPWpGaD
Pyrimethamine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000107	0.00247	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—SLC5A3—kidney cancer	0.000105	0.00241	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PGK1—kidney cancer	0.000105	0.00241	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—LDHB—kidney cancer	0.000103	0.00237	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—BRCA2—kidney cancer	0.000101	0.00233	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—CDKN2B—kidney cancer	0.0001	0.00231	CbGpPWpGaD
Pyrimethamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	9.96e-05	0.00229	CbGpPWpGaD
Pyrimethamine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	9.87e-05	0.00227	CbGpPWpGaD
Pyrimethamine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—kidney cancer	9.83e-05	0.00226	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—BIRC5—kidney cancer	9.68e-05	0.00223	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	9.59e-05	0.00221	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—GSTT1—kidney cancer	9.52e-05	0.00219	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—GSTT1—kidney cancer	9.44e-05	0.00217	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—RPL14—kidney cancer	9.29e-05	0.00214	CbGpPWpGaD
Pyrimethamine—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	9.11e-05	0.0021	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—PTGS1—kidney cancer	8.92e-05	0.00206	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CA9—kidney cancer	8.9e-05	0.00205	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—PTGS1—kidney cancer	8.85e-05	0.00204	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—BIRC5—kidney cancer	8.66e-05	0.00199	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—ITPR2—kidney cancer	8.41e-05	0.00194	CbGpPWpGaD
Pyrimethamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	8.07e-05	0.00186	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—GSTP1—kidney cancer	8.04e-05	0.00185	CbGpPWpGaD
Pyrimethamine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	8e-05	0.00184	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—GSTP1—kidney cancer	7.93e-05	0.00183	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	7.8e-05	0.0018	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CRABP1—kidney cancer	7.57e-05	0.00174	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—GSTM1—kidney cancer	7.39e-05	0.0017	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—GSTM1—kidney cancer	7.29e-05	0.00168	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PSMD7—kidney cancer	7.04e-05	0.00162	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ITPR2—kidney cancer	7.04e-05	0.00162	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—CYP1A1—kidney cancer	7e-05	0.00161	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—CYP1A1—kidney cancer	6.91e-05	0.00159	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—GSTP1—kidney cancer	6.6e-05	0.00152	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—GSTP1—kidney cancer	6.54e-05	0.00151	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	6.51e-05	0.0015	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	6.45e-05	0.00149	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GSTT1—kidney cancer	6.42e-05	0.00148	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ACHE—kidney cancer	6.42e-05	0.00148	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—CDKN2A—kidney cancer	6.42e-05	0.00148	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SLC2A1—kidney cancer	6.37e-05	0.00147	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—JUNB—kidney cancer	6.32e-05	0.00146	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ACY1—kidney cancer	6.16e-05	0.00142	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—SCARB1—kidney cancer	6.08e-05	0.0014	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—GSTM1—kidney cancer	6.07e-05	0.0014	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTGS1—kidney cancer	6.02e-05	0.00139	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—GSTM1—kidney cancer	6.01e-05	0.00139	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	5.98e-05	0.00138	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	5.93e-05	0.00137	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PSMD7—kidney cancer	5.9e-05	0.00136	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	5.75e-05	0.00132	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—CDKN2A—kidney cancer	5.74e-05	0.00132	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	5.7e-05	0.00131	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—CDKN1B—kidney cancer	5.68e-05	0.00131	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	5.67e-05	0.00131	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	5.62e-05	0.00129	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—BCHE—kidney cancer	5.59e-05	0.00129	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—SLC5A5—kidney cancer	5.52e-05	0.00127	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—CCND1—kidney cancer	5.42e-05	0.00125	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—SLC2A1—kidney cancer	5.33e-05	0.00123	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.25e-05	0.00121	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PDHB—kidney cancer	5.24e-05	0.00121	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—POMC—kidney cancer	5.22e-05	0.0012	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CDKN2B—kidney cancer	5.15e-05	0.00119	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—CDKN1B—kidney cancer	5.08e-05	0.00117	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ACY1—kidney cancer	5.06e-05	0.00116	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ACY1—kidney cancer	5.01e-05	0.00115	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CCBL1—kidney cancer	4.93e-05	0.00113	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—CCND1—kidney cancer	4.85e-05	0.00112	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—MAPK3—kidney cancer	4.47e-05	0.00103	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.45e-05	0.00103	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GSTP1—kidney cancer	4.45e-05	0.00102	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—MYC—kidney cancer	4.35e-05	0.001	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PDHB—kidney cancer	4.3e-05	0.000991	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—POMC—kidney cancer	4.29e-05	0.000987	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.28e-05	0.000985	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GLIPR1—kidney cancer	4.27e-05	0.000984	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PPAT—kidney cancer	4.27e-05	0.000984	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PDHB—kidney cancer	4.26e-05	0.000982	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—MAPK1—kidney cancer	4.25e-05	0.00098	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—POMC—kidney cancer	4.25e-05	0.000979	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.22e-05	0.000971	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ABCB1—kidney cancer	4.21e-05	0.00097	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.17e-05	0.000961	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HIF1A—kidney cancer	4.11e-05	0.000948	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TSC2—kidney cancer	4.1e-05	0.000945	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GSTM1—kidney cancer	4.09e-05	0.000942	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CCBL1—kidney cancer	4.04e-05	0.000931	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CCBL1—kidney cancer	4.01e-05	0.000923	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—MAPK3—kidney cancer	4e-05	0.000921	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—FH—kidney cancer	3.97e-05	0.000914	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APRT—kidney cancer	3.97e-05	0.000914	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—MYC—kidney cancer	3.89e-05	0.000896	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.88e-05	0.000894	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CYP1A1—kidney cancer	3.88e-05	0.000893	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—MAPK1—kidney cancer	3.8e-05	0.000876	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GPC3—kidney cancer	3.73e-05	0.00086	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CA2—kidney cancer	3.63e-05	0.000836	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.63e-05	0.000835	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—KIT—kidney cancer	3.63e-05	0.000835	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—APC—kidney cancer	3.63e-05	0.000835	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALAD—kidney cancer	3.54e-05	0.000815	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GLIPR1—kidney cancer	3.51e-05	0.000808	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PPAT—kidney cancer	3.51e-05	0.000808	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GLIPR1—kidney cancer	3.48e-05	0.000801	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPAT—kidney cancer	3.48e-05	0.000801	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ST3GAL2—kidney cancer	3.45e-05	0.000796	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.43e-05	0.00079	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—BRAF—kidney cancer	3.41e-05	0.000785	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.4e-05	0.000782	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALDH1A1—kidney cancer	3.38e-05	0.000778	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APRT—kidney cancer	3.26e-05	0.000751	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—FH—kidney cancer	3.26e-05	0.000751	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PGK1—kidney cancer	3.24e-05	0.000745	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC5A3—kidney cancer	3.24e-05	0.000745	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APRT—kidney cancer	3.23e-05	0.000744	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—FH—kidney cancer	3.23e-05	0.000744	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—TP53—kidney cancer	3.19e-05	0.000735	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LDHB—kidney cancer	3.17e-05	0.000731	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.16e-05	0.000727	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GPC3—kidney cancer	3.06e-05	0.000706	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GPC3—kidney cancer	3.04e-05	0.0007	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CA2—kidney cancer	2.98e-05	0.000687	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CA2—kidney cancer	2.96e-05	0.000681	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALAD—kidney cancer	2.91e-05	0.000669	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—POMC—kidney cancer	2.89e-05	0.000666	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALAD—kidney cancer	2.88e-05	0.000663	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—RAF1—kidney cancer	2.85e-05	0.000655	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.84e-05	0.000653	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—ERBB2—kidney cancer	2.81e-05	0.000648	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.81e-05	0.000647	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MTOR—kidney cancer	2.78e-05	0.00064	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CD4—kidney cancer	2.77e-05	0.000639	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.77e-05	0.000638	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTGS2—kidney cancer	2.75e-05	0.000634	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CA9—kidney cancer	2.75e-05	0.000634	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.75e-05	0.000633	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.69e-05	0.000619	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PGK1—kidney cancer	2.66e-05	0.000612	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.66e-05	0.000612	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PGK1—kidney cancer	2.63e-05	0.000607	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.63e-05	0.000607	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CDKN1B—kidney cancer	2.61e-05	0.0006	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LDHB—kidney cancer	2.61e-05	0.0006	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LDHB—kidney cancer	2.58e-05	0.000595	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CTNNB1—kidney cancer	2.46e-05	0.000567	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTEN—kidney cancer	2.4e-05	0.000553	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CRABP1—kidney cancer	2.34e-05	0.000539	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTGS2—kidney cancer	2.31e-05	0.000531	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CA9—kidney cancer	2.26e-05	0.00052	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CA9—kidney cancer	2.24e-05	0.000516	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.19e-05	0.000504	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ITPR2—kidney cancer	2.18e-05	0.000501	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MAPK3—kidney cancer	2.05e-05	0.000472	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTEN—kidney cancer	2.01e-05	0.000463	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.01e-05	0.000462	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MYC—kidney cancer	1.99e-05	0.000459	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ACHE—kidney cancer	1.98e-05	0.000457	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTT1—kidney cancer	1.98e-05	0.000457	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MAPK1—kidney cancer	1.95e-05	0.000449	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CRABP1—kidney cancer	1.92e-05	0.000442	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CRABP1—kidney cancer	1.9e-05	0.000439	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SCARB1—kidney cancer	1.88e-05	0.000432	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTGS1—kidney cancer	1.86e-05	0.000428	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—KRAS—kidney cancer	1.84e-05	0.000425	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PSMD7—kidney cancer	1.82e-05	0.00042	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ITPR2—kidney cancer	1.79e-05	0.000411	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ITPR2—kidney cancer	1.77e-05	0.000408	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—BCHE—kidney cancer	1.73e-05	0.000398	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.71e-05	0.000393	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PIK3CA—kidney cancer	1.69e-05	0.00039	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC2A1—kidney cancer	1.65e-05	0.00038	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.63e-05	0.000376	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTT1—kidney cancer	1.63e-05	0.000375	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ACHE—kidney cancer	1.63e-05	0.000375	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ACHE—kidney cancer	1.61e-05	0.000372	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTT1—kidney cancer	1.61e-05	0.000372	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.6e-05	0.000368	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SCARB1—kidney cancer	1.54e-05	0.000355	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SCARB1—kidney cancer	1.53e-05	0.000352	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTGS1—kidney cancer	1.53e-05	0.000351	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTGS1—kidney cancer	1.51e-05	0.000348	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PSMD7—kidney cancer	1.5e-05	0.000345	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PSMD7—kidney cancer	1.48e-05	0.000342	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—BCHE—kidney cancer	1.42e-05	0.000327	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CA—kidney cancer	1.42e-05	0.000327	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—BCHE—kidney cancer	1.41e-05	0.000324	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.4e-05	0.000323	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.39e-05	0.000321	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.39e-05	0.00032	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTP1—kidney cancer	1.38e-05	0.000317	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.35e-05	0.000312	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.34e-05	0.000309	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.3e-05	0.0003	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCB1—kidney cancer	1.3e-05	0.0003	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTM1—kidney cancer	1.26e-05	0.000291	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP1A1—kidney cancer	1.2e-05	0.000276	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.14e-05	0.000261	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTP1—kidney cancer	1.13e-05	0.00026	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTP1—kidney cancer	1.12e-05	0.000258	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCB1—kidney cancer	1.07e-05	0.000246	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCB1—kidney cancer	1.06e-05	0.000244	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTM1—kidney cancer	1.04e-05	0.000239	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTM1—kidney cancer	1.03e-05	0.000237	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.84e-06	0.000227	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP1A1—kidney cancer	9.83e-06	0.000226	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP1A1—kidney cancer	9.75e-06	0.000225	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—POMC—kidney cancer	8.93e-06	0.000206	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.01e-06	0.000184	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—POMC—kidney cancer	7.33e-06	0.000169	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—POMC—kidney cancer	7.27e-06	0.000167	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTGS2—kidney cancer	7.12e-06	0.000164	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTEN—kidney cancer	6.21e-06	0.000143	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTGS2—kidney cancer	5.85e-06	0.000135	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTGS2—kidney cancer	5.8e-06	0.000134	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTEN—kidney cancer	5.1e-06	0.000117	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTEN—kidney cancer	5.06e-06	0.000116	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CA—kidney cancer	4.38e-06	0.000101	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CA—kidney cancer	3.6e-06	8.29e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CA—kidney cancer	3.57e-06	8.22e-05	CbGpPWpGaD
